(Source: US House of Representatives Committee on Energy and Commerce) WASHINGTON, DC - In July of 2015, support was surging for H.R. 6, the 21st Century Cures Act. As the House prepared to vote on Cures, resounding support from leading health care experts and thought leaders from both sides of the aisle poured in. Most importantly, over 700 groups encompassing patient advocacy groups, rare disease groups, cancer centers, technology groups, top universities, biopharmaceutical companies, medical device companies, and others from across the country rallied in support of the landmark bill. Momentum continues to grow by the day, especially with partners like Vice President Biden and his Cancer...
↧
